NZ523209A - Antibodies that bind to tumor gene sequences - Google Patents

Antibodies that bind to tumor gene sequences

Info

Publication number
NZ523209A
NZ523209A NZ52320900A NZ52320900A NZ523209A NZ 523209 A NZ523209 A NZ 523209A NZ 52320900 A NZ52320900 A NZ 52320900A NZ 52320900 A NZ52320900 A NZ 52320900A NZ 523209 A NZ523209 A NZ 523209A
Authority
NZ
New Zealand
Prior art keywords
antibodies
bind
gene sequences
tumor gene
tumor
Prior art date
Application number
NZ52320900A
Inventor
Avi J Ashkenazi
Audrey Goddard
Paul Godowski
Austin L Gurney
Kenneth J Hillan
Scot A Marsters
James Pan
Robert M Pitti
Margaret Ann Roy
Victoria Smith
Donna M Stone
Colin K Watanabe
William I Wood
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of NZ523209A publication Critical patent/NZ523209A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NZ52320900A 1999-05-11 2000-02-11 Antibodies that bind to tumor gene sequences NZ523209A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13345999P 1999-05-11 1999-05-11

Publications (1)

Publication Number Publication Date
NZ523209A true NZ523209A (en) 2004-12-24

Family

ID=33538658

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ52320900A NZ523209A (en) 1999-05-11 2000-02-11 Antibodies that bind to tumor gene sequences

Country Status (2)

Country Link
KR (2) KR20050004241A (en)
NZ (1) NZ523209A (en)

Also Published As

Publication number Publication date
KR100512820B1 (en) 2005-09-07
KR20050004241A (en) 2005-01-12
KR20040073587A (en) 2004-08-19

Similar Documents

Publication Publication Date Title
EP1203008A4 (en) Nucleic acid ligands to cd40ligand
AU2440102A (en) Nucleic acid ligands to the prostate specific membrane antigen
HUP0201438A2 (en) Dna vaccine - pcv
IL149491A0 (en) Nucleic acid-containing complex
GB9911569D0 (en) Antibodies
HUP0202221A1 (en) Tenascin-c nucleic acid lagands
PL356770A1 (en) Use of anti-idiotypical antibodies as vaccines against cancer
EP1218413A4 (en) Engineering antibodies that bind irreversibly
AU2002351374A8 (en) Antibodies to treat cancer
IL158184A0 (en) Anti-muc-1 single chain antibodies for tumor targeting
GB9928950D0 (en) Binding protein
EP1165767A4 (en) Dna binding proteins that interact with npr1
NZ523207A (en) Antibodies that bind to tumor gene sequences
NZ523209A (en) Antibodies that bind to tumor gene sequences
EP1454914A4 (en) Tumor antigen
EP1237929A4 (en) Dendritic cell-specific antibodies
EP1225222A4 (en) Novel tumor suppressor gene
EP1403283A4 (en) Tumor antigen
GB9905644D0 (en) Dna
EP1446416A4 (en) Tumor specific monoclonal antibodies
GB9925491D0 (en) Genetic biosensors using chemiluminescence
IL132710A0 (en) Catalytic nucleic acid sequences
GB9910348D0 (en) Novel DNA sequences
EP1235840A4 (en) Methods for identifying compounds that affect rna/rna binding protein interactions
GB9928197D0 (en) 85kDA antigen

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)